[CONSOLIDATION_METHOD_TITLE] [CONSOLIDATION_METHOD]
Related Companies
[]
Related Funds
[]
English
oda_NoncurrentFinancialAssetAcquisitionAbstract|
Noncurrent Financial Asset Acquisition
oda_UpdateAnnouncementFlag|
Update Notification Flag
Hayır (No)
oda_CorrectionAnnouncementFlag|
Correction Notification Flag
Hayır (No)
oda_DateOfThePreviousNotificationAboutTheSameSubject|
Date Of The Previous Notification About The Same Subject
-
oda_DelayedAnnouncementFlag|
Postponed Notification Flag
Hayır (No)
oda_AnnouncementContentSection|
Announcement Content
oda_BoardDecisionDateForAcquisition|
Board Decision Date for Acquisition
13/05/2023
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForAcquisition|
Were Majority of Independent Board Members' Approved the Board Decision for Acquisition
Yes
oda_TitleOfNoncurrentFinancialAssetAcquired|
Title of Non-current Financial Asset Acquired
Neo Auvra Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş.
oda_FieldOfActivityNoncurrentFinancialAssetWhoseSharesWereAcquired|
Field of Activity of Non-current Financial Asset whose Shares were being Acquired
Digital Healt Technologies
oda_CapitalOfNoncurrentFinancialAsset|
Capital of Noncurrent Financial Asset
12.250.000
oda_AcquirementWay|
Acquirement Way
Sermaye Artırımı Yoluyla Edinim (Capital Increase)
oda_DateOnWhichTheTransactionWasWillBeCompleted|
Date on which the Transaction was/will be Completed
Registration and announcement of General Meeting
oda_AcquisitionConditions|
Acquisition Conditions
Diğer (Other)
oda_DetailedConditionsIfItIsATimedPayment|
Detailed Conditions if it is a Timed Payment
-
oda_NominalValueOfSharesAcquired|
Nominal Value of Shares Acquired
591.548
oda_PurchasePricePerShare|
Purchase Price Per Share
USD 2,57
oda_TotalPurchasingValue|
Total Purchasing Value
USD 1.520.000
oda_RatioOfNewSharesAcquiredToCapitalOfNoncurrentFinancialAsset|
Ratio of New Shares Acquired to Capital of Non-current Financial Asset (%)
4,61
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterTransaction|
Total Ratio of Shares Owned in Capital of Non-current Financial Asset After Transaction (%)
12,39
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterTransaction|
Total Voting Right Ratio Owned in Non-current Financial Asset After Transaction (%)
12,39
oda_RatioOfNoncurrentFinancialAssetAcquiredToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
Ratio of Non-current Financial Asset Acquired to Total Assets in Latest Disclosed Financial Statements of Company (%)
0,72
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
Ratio of Transaction Value to Sales in Latest Annual Financial Statements of Company (%)
0,54
oda_EffectsOnCompanyOperations|
Effects on Company Operations
Positive Impact is expected
oda_DidTakeoverBidObligationArised|
Did Takeover Bid Obligation Arised?
Hayır (No)
oda_WillExemptionApplicationBeMadeIfTakeoverBidObligationArised|
Will Exemption Application be Made, if Takeover Bid Obligation Arised?
Hayır (No)
oda_TitleNameSurnameOfCounterParty|
Title/ Name-Surname of Counter Party
Acquired through capital increase
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
Is Counter Party a Related Party According to CMB Regulations?
Evet (Yes)
oda_RelationWithCounterPartyIfAny|
Relation with Counter Party if any
GEN is currently shareholder of the company
oda_AgreementSigningDateIfExists|
Agreement Signing Date if Exists
15/05/2023
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
Value Determination Method of Non-current Financial Asset
Discount made on value determined with valuation report.
oda_DidValuationReportBePrepared|
Did Valuation Report be Prepared?
Düzenlendi (Prepared)
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
Reason for not Preparing Valuation Report if it was not Prepared
-
oda_DateAndNumberOfValuationReport|
Date and Number of Valuation Report
05.05.2023 - GLB KF 2023/05
oda_TitleOfValuationCompanyPreparedReport|
Title of Valuation Company Prepared Report
Global Menkul Değerler A.Ş.
oda_ValueDeterminedInValuationReportIfExists|
Value Determined in Valuation Report if Exists
41.245.070 USD
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
Reasons if Transaction wasn't/will not be performed in Accordance with Valuation Report
Detailed information given below.
oda_ExplanationSection|
Explanations
oda_ExplanationTextBlock|

In the disclosure made by our company on 14/11/2022 Public Disclosure Platform (KAP) ( https://www.kap.org.tr/tr/Bildirim/1079772 ) convertible loan amounting to USD 1.000.000 (OneMillionUSDollars) lended to Neo Auvra Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş. (Neo Auvra) which GEN is 8,16% shareholder and has activities  for the Neo Auvra'a growth oriented projects.

General Meeting made  including the agenda capital increase for the conversion to the share and acquisition of shares issued in return to the financing provided by GEN. As a result of general meeting capital increase is made and shares issued in return to the convertible loan acquired by GEN within the conditions determined on convertible loan agreement signed between our Company and Neo Auvra.

Before this General Meeting Board of Directors of GEN decided to make additional investment amounting to USD 500.000 (FiveHundredThousandUSDollars)

4,61% Neo Auvra shares acquired in return to the total USD 1.520.000 (OneMillionFiveHundredTwentyThousanUSDollars) investment including USD 1.000.000 (OneMillionUSDollars) convertible loan, USD 20.000 (TwentyThousandUSDollars) interest on debt and additonal investment made on 15/05/2023 amounting to USD 500.000 (FiveHundredThousandUSDollars)

Amount of shares which acquired after conversion is calculated by making 20% discount to the company value determined on the valuation report prepared by Global Menkul Değerler A.Ş. on 05/05/2023.

As a result of the registration and announcement of the General Meeting shareholder ratio of GEN will raise to the 12,39% to the 8,16%